Rivaroxaban for Scheduled Work-up of DVT - The Ri-Schedule Study

Summary

This prospective outcome study is designed to assess the safety of rivaroxaban in the pre-diagnosis phase of DVT.

Timeline

Start

2015-03

Primary completion

2018-11-30

Completion

2018-12-30

Publications

• Mohamad H, Jorgensen CT, Ghanima W, Tavoly M, Fronas SG. Clinical use and safety of empiric anticoagulation during diagnostic work-up for deep vein thrombosis. Hematology. 2025 Dec;30(1):2573586. doi: 10.1080/16078454.2025.2573586. Epub 2025 Oct 20.
• Fronas SG, Jorgensen CT, Dahm AEA, Wik HS, Gleditsch J, Raouf N, Holst R, Klok FA, Ghanima W. Safety of a strategy combining D-dimer testing and whole-leg ultrasonography to rule out deep vein thrombosis. Blood Adv. 2020 Oct 27;4(20):5002-5010. doi: 10.1182/bloodadvances.2020002173.
• Fronas SG, Dahm AEA, Wik HS, Jorgensen CT, Gleditsch J, Raouf N, Holst R, Klok FA, Ghanima W. Safety and feasibility of rivaroxaban in deferred workup of patients with suspected deep vein thrombosis. Blood Adv. 2020 Jun 9;4(11):2468-2476. doi: 10.1182/bloodadvances.2020001556.

Drugs

Indications